Form 4 for TER Teradyne
Accepted 2026-05-19 14:27:41 ET · period of report 2026-05-15 · accession 0000904454-26-000306 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-19 14:27 | 2026-05-15 | TER | Smith Gregory Stephen | Pres, CEO, Dir | M - OptEx | $72.10 | +4,597 | 133.1K | +4% | +$331.4K |
| DT | 2026-05-19 14:27 | 2026-05-15 | TER | Smith Gregory Stephen | Pres, CEO, Dir | S - Sale+OE | $338.98 | -8,597 | 124.5K | -6% | -$2.91M |
| DT | 2026-05-19 14:27 | 2026-05-15 | TER | Smith Gregory Stephen | Pres, CEO, Dir | M - OptEx | $0.00 | -4,597 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-15 | M | A | 4,597 | $72.10 | 133,066.57 | D | — | — | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 12, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 2 | Common | Common Stock | 2026-05-15 | S | D | 8,597 | $338.98 | 124,469.57 | D | — | — | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 12, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-15 | M | D | 4,597 | $0.00 | 0 | D | $72.10 · — to 2027-01-24 | 4,597 Common Stock | (F1) The reported transactions were effected pursuant to a sales plan adopted by the Reporting Person on February 12, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. (F2) This option was granted under the Issuer's 2006 Equity and Cash Compensation Incentive Plan, and became exercisable at the rate of 25% per year beginning on January 24, 2021, the first anniversary of the grant. |